The influence of deferiprone (L1) and deferoxamine on iron and essential element tissue level and parameters of oxidative status in dietary iron-loaded mice
- 10 March 2002
- journal article
- research article
- Published by Elsevier in Toxicology Letters
- Vol. 128 (1-3) , 169-175
- https://doi.org/10.1016/s0378-4274(01)00541-0
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Transfusional iron overload and chelation therapy with deferoxamine and deferiprone (L1)Transfusion Science, 2000
- Protective effects of thymoquinone and desferrioxamine against hepatotoxicity of carbon tetrachloride in miceLife Sciences, 2000
- The therapeutic potential of iron chelatorsExpert Opinion on Investigational Drugs, 1999
- Non-transferrin-bound-iron in serum and low-molecular-weight-iron in the liver of dietary iron-loaded ratsInternational Journal of Biochemistry, 1993
- Metabolism of iron from (3,5,5-trimethylhexanoyl) ferrocene in rats: A dietary model for severe iron overloadBiochemical Pharmacology, 1993
- Efficacy and possible adverse effects of the oral iron chelator 1,2- dimethyl-3-hydroxypyrid-4-one (L1) in thalassemia major [see comments]Blood, 1992
- Determination of malonaldehyde precursor in tissues by thiobarbituric acid testAnalytical Biochemistry, 1978
- Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagentAnalytical Biochemistry, 1968